Literature DB >> 17543425

Human metapneumovirus: enhanced pulmonary disease in cotton rats immunized with formalin-inactivated virus vaccine and challenged.

Kevin C Yim1, Rose P Cragin, Marina S Boukhvalova, Jorge C G Blanco, Marie-Eve Hamlin, Guy Boivin, David D Porter, Gregory A Prince.   

Abstract

Cotton rats (Sigmodon hispidus) are susceptible to the recently discovered human metapneumovirus (hMPV), an agent closely related to human respiratory syncytial virus. Since certain respiratory syncytial virus vaccines can induce enhanced disease upon viral challenge, we have done similar experiments with hMPV in cotton rats. Young adult cotton rats were vaccinated with a formalin-inactivated preparation of hMPV strain C-85473, or with a mock preparation of the vaccine on day 0 and again on day 28. All animals were challenged intranasally on day 49 with 10(7) TCID50 of the same hMPV strain. Animals were sacrificed on days 4, 7, and 10 post-challenge and lungs were removed for viral quantitation, histopathology, and cytokine mRNA expression analysis (interferon-gamma (IFN-gamma) and interleukin-4 (IL-4)). Although the vaccinated animals showed almost complete protection from viral replication in the lungs (<10(2.0) TCID50 per gram), there was a dramatic increase in the lung pathology, particularly the interstitial pneumonitis and alveolitis with elevated serum neutralizing antibody titer prior to challenge. Cytokine profiles were distinctive from those observed during primary infection and re-infection. The data raise safety concerns for hMPV vaccine preparations.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17543425      PMCID: PMC1937335          DOI: 10.1016/j.vaccine.2007.04.075

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  30 in total

1.  The cotton rat: an underutilized animal model for human infectious diseases can now be exploited using specific reagents to cytokines, chemokines, and interferons.

Authors:  Jorge C G Blanco; Lioubov Pletneva; Marina Boukhvalova; Joann Y Richardson; Katie A Harris; Gregory A Prince
Journal:  J Interferon Cytokine Res       Date:  2004-01       Impact factor: 2.607

2.  Pathogenesis of human metapneumovirus lung infection in BALB/c mice and cotton rats.

Authors:  Marie-Eve Hamelin; Kevin Yim; Katie H Kuhn; Rose P Cragin; Marina Boukhvalova; Jorge C G Blanco; Gregory A Prince; Guy Boivin
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

3.  Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine.

Authors:  H W Kim; J G Canchola; C D Brandt; G Pyles; R M Chanock; K Jensen; R H Parrott
Journal:  Am J Epidemiol       Date:  1969-04       Impact factor: 4.897

4.  Development of a cotton rat-human metapneumovirus (hMPV) model for identifying and evaluating potential hMPV antivirals and vaccines.

Authors:  Philip R Wyde; Srikrishna N Chetty; Alan M Jewell; Shauna L Schoonover; Pedro A Piedra
Journal:  Antiviral Res       Date:  2005-04       Impact factor: 5.970

5.  Production of atypical measles in rhesus macaques: evidence for disease mediated by immune complex formation and eosinophils in the presence of fusion-inhibiting antibody.

Authors:  F P Polack; P G Auwaerter; S H Lee; H C Nousari; A Valsamakis; K M Leiferman; A Diwan; R J Adams; D E Griffin
Journal:  Nat Med       Date:  1999-06       Impact factor: 53.440

6.  The two major human metapneumovirus genetic lineages are highly related antigenically, and the fusion (F) protein is a major contributor to this antigenic relatedness.

Authors:  Mario H Skiadopoulos; Stéphane Biacchesi; Ursula J Buchholz; Jeffrey M Riggs; Sonja R Surman; Emerito Amaro-Carambot; Josephine M McAuliffe; William R Elkins; Marisa St Claire; Peter L Collins; Brian R Murphy
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

7.  Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children.

Authors:  John V Williams; Paul A Harris; Sharon J Tollefson; Lisa L Halburnt-Rush; Joyce M Pingsterhaus; Kathryn M Edwards; Peter F Wright; James E Crowe
Journal:  N Engl J Med       Date:  2004-01-29       Impact factor: 91.245

8.  Altered reactivity to measles virus. Atypical measles in children previously immunized with inactivated measles virus vaccines.

Authors:  V A Fulginiti; J J Eller; A W Downie; C H Kempe
Journal:  JAMA       Date:  1967-12-18       Impact factor: 56.272

9.  Identification of small-animal and primate models for evaluation of vaccine candidates for human metapneumovirus (hMPV) and implications for hMPV vaccine design.

Authors:  Mia MacPhail; Jeanne H Schickli; Roderick S Tang; Jasmine Kaur; Christopher Robinson; Ron A M Fouchier; Albert D M E Osterhaus; Richard R Spaete; Aurelia A Haller
Journal:  J Gen Virol       Date:  2004-06       Impact factor: 3.891

10.  Experimental human metapneumovirus infection of cynomolgus macaques (Macaca fascicularis) results in virus replication in ciliated epithelial cells and pneumocytes with associated lesions throughout the respiratory tract.

Authors:  Thijs Kuiken; Bernadette G van den Hoogen; Debby A J van Riel; Jon D Laman; Geert van Amerongen; Leo Sprong; Ron A M Fouchier; Albert D M E Osterhaus
Journal:  Am J Pathol       Date:  2004-06       Impact factor: 4.307

View more
  26 in total

Review 1.  Recent vaccine development for human metapneumovirus.

Authors:  J Ren; T Phan; X Bao
Journal:  J Gen Virol       Date:  2015-02-09       Impact factor: 3.891

2.  Novel HLA-A2-restricted human metapneumovirus epitopes reduce viral titers in mice and are recognized by human T cells.

Authors:  Andrew K Hastings; Pavlo Gilchuk; Sebastian Joyce; John V Williams
Journal:  Vaccine       Date:  2016-04-19       Impact factor: 3.641

Review 3.  New Approaches for Immunization and Therapy against Human Metapneumovirus.

Authors:  Sherry C Wen; John V Williams
Journal:  Clin Vaccine Immunol       Date:  2015-06-10

Review 4.  New insights for development of a safe and protective RSV vaccine.

Authors:  Jorge C G Blanco; Marina S Boukhvalova; Kari Ann Shirey; Gregory A Prince; Stefanie N Vogel
Journal:  Hum Vaccin       Date:  2010-06-01

Review 5.  Modulation of Host Immunity by the Human Metapneumovirus.

Authors:  Pablo F Céspedes; Christian E Palavecino; Alexis M Kalergis; Susan M Bueno
Journal:  Clin Microbiol Rev       Date:  2016-10       Impact factor: 26.132

6.  Zinc binding activity of human metapneumovirus M2-1 protein is indispensable for viral replication and pathogenesis in vivo.

Authors:  Hui Cai; Yu Zhang; Yuanmei Ma; Jing Sun; Xueya Liang; Jianrong Li
Journal:  J Virol       Date:  2015-04-08       Impact factor: 5.103

7.  Human metapneumovirus virus-like particles induce protective B and T cell responses in a mouse model.

Authors:  Reagan G Cox; John J Erickson; Andrew K Hastings; Jennifer C Becker; Monika Johnson; Ryan E Craven; Sharon J Tollefson; Kelli L Boyd; John V Williams
Journal:  J Virol       Date:  2014-03-26       Impact factor: 5.103

8.  An alphavirus replicon-based human metapneumovirus vaccine is immunogenic and protective in mice and cotton rats.

Authors:  Hoyin Mok; Sharon J Tollefson; Amy B Podsiad; Bryan E Shepherd; Vasiliy V Polosukhin; Robert E Johnston; John V Williams; James E Crowe
Journal:  J Virol       Date:  2008-09-10       Impact factor: 5.103

9.  Rational design of human metapneumovirus live attenuated vaccine candidates by inhibiting viral mRNA cap methyltransferase.

Authors:  Yu Zhang; Yongwei Wei; Xiaodong Zhang; Hui Cai; Stefan Niewiesk; Jianrong Li
Journal:  J Virol       Date:  2014-07-23       Impact factor: 5.103

10.  The cotton rat model of respiratory viral infections.

Authors:  Marina S Boukhvalova; Gregory A Prince; Jorge C G Blanco
Journal:  Biologicals       Date:  2009-04-25       Impact factor: 1.856

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.